Search Results - "Oterino, Agustin"
-
1
MAB-MIG: registry of the spanish neurological society of erenumab for migraine prevention
Published in Journal of headache and pain (17-07-2021)“…Background Erenumab was approved in Europe for migraine prevention in patients with ≥ 4 monthly migraine days (MMDs). In Spain, Novartis started a personalized…”
Get full text
Journal Article -
2
Serum CGRP, VIP, and PACAP usefulness in migraine: a case–control study in chronic migraine patients in real clinical practice
Published in Molecular biology reports (01-09-2020)“…Calcitonin gene-related peptide (CGRP), vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypetide-38 (PACAP-38) have relevant…”
Get full text
Journal Article -
3
Systemic and cerebral endothelial dysfunction in chronic migraine. A case-control study with an active comparator
Published in Cephalalgia (01-05-2016)“…Unlike migraine and migraine with aura, little information exists regarding chronic migraine (CM) as a risk factor for cardiovascular disease. In this study we…”
Get more information
Journal Article -
4
IgG-mediated allergy: a new mechanism for migraine attacks?
Published in Cephalalgia (01-07-2010)Get more information
Journal Article -
5
Headaches precipitated by cough, prolonged exercise or sexual activity: a prospective etiological and clinical study
Published in Journal of headache and pain (01-10-2008)“…Headaches provoked by cough, prolonged physical exercise and sexual activity have not been studied prospectively, clinically and neuroradiologically. Our aim…”
Get full text
Journal Article -
6
Creutzfeldt–Jakob-like syndrome secondary to severe lithium intoxication: A detailed follow-up electroencephalographic study
Published in Clinical neurophysiology (01-11-2014)Get full text
Journal Article -
7
Long-Term Evolution of Chronic Daily Headache With Medication Overuse in the General Population
Published in Headache (01-06-2010)“…(Headache 2010;50:981‐988) Objective.— To investigate long‐term efficiency of an intervention protocol for chronic daily headache with medication overuse…”
Get full text
Journal Article -
8
Multi-centre validation of a flow cytometry method to identify optimal responders to interferon-beta in multiple sclerosis
Published in Clinica chimica acta (01-01-2019)“…Percentages of blood CD19+CD5+ B cells and CD8+perforin+ T lymphocytes can predict response to Interferon (IFN)-beta treatment in relapsing-remitting multiple…”
Get full text
Journal Article -
9
Genetic factors associated with drug-resistance of epilepsy: Relevance of stratification by patient age and aetiology of epilepsy
Published in Seizure (London, England) (01-03-2010)“…Abstract Epilepsy drug-resistance may depend on the metabolism of antiepileptic drugs (AEDs), transport to the epileptic focus and/or target sensitivity…”
Get full text
Journal Article -
10
Utility of treatment with atorvastatin 40 mg plus ezetimibe 10 mg versus atorvastatin 80 mg in reducing the levels of LDL cholesterol in patients with ischaemic stroke or transient ischaemic attack
Published in Revista de neurologiá (01-03-2016)“…After an ischaemic stroke, to reduce LDL cholesterol (LDLc) levels decreases the risk of recurrence. The risk of recurrence is lower with more intense…”
Get full text
Journal Article -
11
Migraine as a potential risk factor for ischemic lesions: Recent findings
Published in Current pain and headache reports (01-10-2009)Get full text
Journal Article -
12
Review of the novelties presented at the 2018 ECTRIMS Congress: 11th Post-ECTRIMS Meeting (I)
Published in Revista de neurologiá (16-05-2019)“…The Post-ECTRIMS Meeting is an emblematic event in Spain which seeks to review and disseminate the main advances in multiple sclerosis presented at the ECTRIMS…”
Get full text
Journal Article -
13
LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease
Published in Neuroscience letters (13-03-2006)“…Mutations in the leucine-rich repat kinase 2 ( LRRK2) gene have been shown to cause both autosomal dominant and sporadic Parkinson's disease (PD). The common…”
Get full text
Journal Article -
14
Family-Based Association Study of Chromosome 6p12.2-p21.1 Migraine Locus
Published in Headache (01-03-2012)“…Background.— One of the genome‐wide linkage studies performed in migraine has yielded a significant linkage of migraine (with and without aura) with markers…”
Get full text
Journal Article -
15
Poly (ADP-ribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease
Published in Journal of the neurological sciences (15-05-2007)“…Abstract Poly (ADP-ribose) polymerase-1 (PARP-1) is involved in crucial pathogenic events in Parkinson's disease (PD). We studied the effect of promoter…”
Get full text
Journal Article -
16
Association of migraine and ESRI G325C polymorphism
Published in Neuroreport (2006)Get full text
Journal Article -
17
Lack of Association of Endothelial Nitric Oxide Synthase Polymorphisms and Migraine
Published in Headache (01-07-2008)“…Objective.— The aim of this study was to evaluate if 2 functional endothelial nitric oxide synthase (eNOS) gene polymorphisms might be risk factors for…”
Get full text
Journal Article -
18
No evidence of association between common European mitochondrial DNA variants in Alzheimer, Parkinson, and migraine in the Spanish population
Published in American journal of medical genetics. Part B, Neuropsychiatric genetics (01-01-2015)“…Certain mitochondrial DNA (mtDNA) variants and haplogroups have been found to be associated with neurological disorders. Several studies have suggested that…”
Get full text
Journal Article -
19
Zonisamide in the preventive treatment of refractory migraine
Published in Revista de neurologiá (01-02-2010)“…Chronic migraine refractory to preventive treatment is a common clinical situation in general neurology clinics. The aim is to analyse our experience with…”
Get full text
Journal Article -
20
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
Published in Journal of headache and pain (22-11-2023)“…Background Galcanezumab has shown efficacy and effectiveness in the treatment of episodic and chronic migraine (CM), however, the population represented in…”
Get full text
Journal Article